BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18600319)

  • 1. Distant metastases and synchronous second primary tumors in patients with newly diagnosed oropharyngeal and hypopharyngeal carcinomas: evaluation of (18)F-FDG PET and extended-field multi-detector row CT.
    Ng SH; Chan SC; Liao CT; Chang JT; Ko SF; Wang HM; Chin SC; Lin CY; Huang SF; Yen TC
    Neuroradiology; 2008 Nov; 50(11):969-79. PubMed ID: 18600319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ¹⁸F-FDG PET/CT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngeal/hypopharyngeal carcinoma: a comparative study.
    Chan SC; Wang HM; Yen TC; Lin CY; Chin SC; Liao CT; Wai YY; Wang JJ; Ng SH
    Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1607-19. PubMed ID: 21567252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DaPeCa-7: comparative assessment of fluorodeoxyglucose positron emission tomography/computed tomography (CT) and conventional diagnostic CT in diagnosis of lymph node metastases, distant metastases and incidental findings in patients with invasive penile cancer.
    Jakobsen JK; Frahm Nielsen T; Ipsen P; Albrecht-Beste E; Cardoso Costa J; Alslev L; Predbjørn Krarup K; Grønkaer Toft B; Høyer S; Bouchelouche K; Bjerggaard Jensen J
    BJU Int; 2021 Feb; 127(2):254-262. PubMed ID: 33448605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET/CT and 3-T whole-body MRI in the detection of malignancy in treated oropharyngeal and hypopharyngeal carcinoma.
    Ng SH; Chan SC; Yen TC; Liao CT; Lin CY; Tung-Chieh Chang J; Ko SF; Wang HM; Chang KP; Fan KH
    Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):996-1008. PubMed ID: 21327634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced MRI, diffusion-weighted MRI and
    Ng SH; Liao CT; Lin CY; Chan SC; Lin YC; Yen TC; Chang JT; Ko SF; Fan KH; Wang HM; Yang LY; Wang JJ
    Eur Radiol; 2016 Nov; 26(11):4162-4172. PubMed ID: 26911889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of 18F-fluorodeoxyglucose positron emission tomography in the preoperative staging of squamous cell carcinoma of the oropharynx.
    Kim MR; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Eur J Surg Oncol; 2007 Jun; 33(5):633-8. PubMed ID: 17391904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.
    Ng SH; Lin CY; Chan SC; Lin YC; Yen TC; Liao CT; Chang JT; Ko SF; Wang HM; Chang CJ; Wang JJ
    PLoS One; 2014; 9(12):e115933. PubMed ID: 25531391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FDG PET for retropharyngeal lymph node metastasis in oropharyngeal and hypopharyngeal cancers: impact on diagnosis and prediction analysis.
    Chan SC; Lin CY; Ng SH; Chang JT; Wang HM; Liao CT; Lo CW; Yen TC
    Nucl Med Commun; 2010 Mar; 31(3):260-5. PubMed ID: 20072075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
    Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
    J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
    Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
    J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma.
    Haerle SK; Strobel K; Hany TF; Sidler D; Stoeckli SJ
    Head Neck; 2010 Mar; 32(3):319-25. PubMed ID: 19626642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing central compartment neck dissection for squamous cell carcinoma of the larynx, hypopharynx, and esophagus.
    Kim JW; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2013 May; 49(5):449-53. PubMed ID: 23321549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDG PET as a routine posttreatment surveillance tool in oral and oropharyngeal squamous cell carcinoma: a prospective study.
    Krabbe CA; Pruim J; Dijkstra PU; Balink H; van der Laan BF; de Visscher JG; Roodenburg JL
    J Nucl Med; 2009 Dec; 50(12):1940-7. PubMed ID: 19910434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer.
    Kim SY; Roh JL; Yeo NK; Kim JS; Lee JH; Choi SH; Nam SY
    Ann Oncol; 2007 Oct; 18(10):1698-703. PubMed ID: 17716985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of FDG-PET for detecting multiple primary cancers in hypopharyngeal cancer patients.
    Kaida H; Ishibashi M; Kurata S; Uchiyama Y; Tanaka N; Abe T; Kobayashi M; Kaibara H; Uchida M; Nakashima T; Fujita H; Hayabuchi N
    Nuklearmedizin; 2009; 48(5):179-84. PubMed ID: 19639163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas.
    Laubenbacher C; Saumweber D; Wagner-Manslau C; Kau RJ; Herz M; Avril N; Ziegler S; Kruschke C; Arnold W; Schwaiger M
    J Nucl Med; 1995 Oct; 36(10):1747-57. PubMed ID: 7562038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of
    Yeh CH; Chan SC; Lin CY; Yen TC; Chang JT; Ko SF; Fan KH; Wang HM; Liao CT; Ng SH
    Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):94-104. PubMed ID: 31606831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative staging of biliary carcinoma using 18F-fluorodeoxyglucose PET: prospective comparison with PET+CT, MDCT and histopathology.
    Furukawa H; Ikuma H; Asakura-Yokoe K; Uesaka K
    Eur Radiol; 2008 Dec; 18(12):2841-7. PubMed ID: 18509655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical usefulness of [18F]FDG PET-CT and CT/MRI for detecting nodal metastasis in patients with hypopharyngeal squamous cell carcinoma.
    Shin NY; Lee JH; Kang WJ; Koh YW; Sohn B; Kim J
    Ann Surg Oncol; 2015 Mar; 22(3):994-9. PubMed ID: 25201502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.